Status:
COMPLETED
Discontinuation of Antidepressant Medication in Primary Care.
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Pro Persona Mental Health Care Foundation
Innovatiefonds Zorgverzekeraars
Conditions:
Antidepressants
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
To investigate the effectiveness of the combination of Supported Protocolized Discontinuation (SPD) and Mindfulness-Based Cognitive Therapy (MBCT) in comparison with SPD alone in successful discontinu...
Detailed Description
Antidepressant use continues to rise, mainly explained by an increase in the proportion of patients receiving long term treatment. Although treatment guidelines recommend discontinuation after sustain...
Eligibility Criteria
Inclusion
- • Having received prescriptions for antidepressants in primary care for at least the past nine months
Exclusion
- Current treatment by a psychiatrist
- Current diagnosis of substance use disorder
- Non-psychiatric indication for long-term antidepressant usage (i.e. neuropathic pain)
- Having participated in a mindfulness training (\> 3 sessions) within the last 5 years
- Inability to perform the assessments due to cognitive or language difficulties
- Younger than 18 years
Key Trial Info
Start Date :
February 20 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT03361514
Start Date
February 20 2017
End Date
August 1 2019
Last Update
February 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Medical Centre for Mindfulness, Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands, 6500HB